Looking Back on 2025

2025 was Metacarpal’s fifth year. It was also a year where many things that had been in progress for a long time finally began to take shape.

We started the year by launching Metacarpal Inc., alongside a refreshed brand and visual identity. It wasn’t about reinvention as much as clarity — a way to better reflect what we’ve been working toward and what we hope to build next.

Over the course of the year, we made a number of important steps forward. We hired our first US-based employee, Erica Karlson to lead North American sales and began establishing a presence in the US. We completed our first production orders, created our first user manual, delivered our first manufactured hand, ran our first webinar, and supported our first successful insurance claims. There were many small milestones too, some planned, some unexpected, and some we’re still learning from.

Together, these moments marked a transition. We moved from testing assumptions about what people might want, to better understanding what people actually use and value in everyday life.

One piece of feedback kept coming back to us: people were surprised that something like GEM hadn’t existed sooner.

GEM reflects years of iteration, missteps, and refinement. It took time to build something that is mechanically complex but simple to use, durable enough for real-world use, and reliable enough to earn trust. That process wasn’t quick, and it wasn’t straightforward.

What mattered most this year were the experiences of users. We heard stories about first attempts and small wins: tying shoelaces, washing dishes, using tools, operating machinery, doing tasks that many people don’t think twice about. These moments may seem ordinary, but they aren’t.

We’re still early in this journey. There’s more to improve, more to learn, and more people we hope to support.

In 2026, our focus will be on carefully expanding access to GEM, including in regions where we know there’s strong interest. We’ll move at a pace that allows us to properly support users and clinicians, and to keep learning as we go.

Thank you to everyone who has been part of this year — users, clinicians, partners, and the team behind the scenes. We’re grateful for the trust, and we don’t take it lightly.

Share it on:

More insights